← Back to Search

Behavioural Intervention

Exercise for Prostate Cancer (EMMPC Trial)

N/A

Waitlist Available

Led By Peter Black, MD

Research Sponsored by Vancouver Prostate Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age over 19

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery

Awards & highlights

EMMPC Trial Summary

This trial is testing whether an exercise program can improve outcomes for men with prostate cancer.

Who is the study for?

This trial is for men over 19 with prostate cancer who are fit for radical prostatectomy, do less than 90 minutes of moderate exercise weekly, have a BMI under 40, and can speak English. They must commit to the study schedule including twice-weekly visits for exercise and be able to give informed consent.Check my eligibility

What is being tested?

The study tests if an exercise program before surgery can affect disease progression in prostate cancer patients. Participants will either join a 4-12 week exercise regimen or receive standard care only, with assessments throughout the intervention and up to six months after surgery.See study design

What are the potential side effects?

Since this trial involves an exercise program rather than medication, side effects may include typical physical responses to increased activity such as muscle soreness or fatigue but should generally be minimal.

EMMPC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am older than 19 years.

EMMPC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility: Number of patients enrolled per month

Feasibility: Number of patients screened per month

Feasibility: Proportion of planned assessments that are completed respectively

+3 more

Secondary outcome measures

Biological: Collection of urine, blood, biopsy and RP specimens

Physical Fitness: Aerobic fitness using a submaximal graded exercise test

Physical Fitness: Anthropometrics (i.e. BMI & waist circumference)

+8 more

EMMPC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ARM1: Exercise InterventionExperimental Treatment1 Intervention

The exercise program is a 4-12 weeks progressive combined resistance and aerobic exercise for participants from time of diagnosis to RP. Participants will undergo twice weekly group-training (four-six participants/group) combined aerobic-resistance sessions (1hr per session), supervised by trained exercise therapists. In addition, participants will undergo home-based aerobic exercise independently three times a week with the goal to meet the current physical activity guidelines for cancer survivors (150min/week of moderate intensity aerobic activity and two resistance training sessions per week). Participants will also be supplied with the Canadian Physical Activity and Sedentary Behavior Guidelines Handbook and accompanying Log Sheets.

Group II: ARM2: Control GroupActive Control1 Intervention

Participants will be asked to exercise as they normally would and will be asked to record their exercise activity on provided activity logs.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vancouver Prostate CentreLead Sponsor

9 Previous Clinical Trials

855 Total Patients Enrolled

5 Trials studying Prostate Cancer

373 Patients Enrolled for Prostate Cancer

Peter Black, MDPrincipal InvestigatorDepartment of Urologic Sciences, University of British Columbia

1 Previous Clinical Trials

32 Total Patients Enrolled

Media Library

Exercise (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02481648 — N/A

Prostate Cancer Research Study Groups: ARM1: Exercise Intervention, ARM2: Control Group

Prostate Cancer Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT02481648 — N/A

Exercise (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02481648 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are further participants needed to join this experiment?

"At present, the trial posted on July 1st 2015 and most recently updated April 17th 2023 is not actively seeking new participants. Nonetheless, 1407 other studies are open to volunteers right now."

Answered by AI

What are the primary endpoints of this trial?

"The primary goal of this medical research project, extending from the start to end of recruitment, is determining feasibility in terms of patient enrolment per month. Secondary objectives include psychosocial measurements via International Prostate Symptom Score (IPSS) comparison between baseline and the conclusion of study; biological sample collection such as urine, blood, biopsy & RP specimens for each participant; physical fitness examination using a submaximal graded exercise test with results compared against baseline scores at the termination of trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer

2015. "Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02481648.